Besides PFIC-2, mutations or insufficiency of BSEP is associated with a variety of diseases such as drug-induced cholestasis, pregnancy induced cholestasis, cryptogenic cholestasis, cholangiocarcinoma and hepatocellular carcinoma, which are cancers of the liver3–7. This evidence concerns the gene ABCB11 and cholestasis.